BLRX News and Press, BioLineRx Ltd. From 04/22/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Thursday comes and with it, another busy day of trading begins. Before the opening bell rings, let’s examine the top pre-market movers that investors need to keep an eye on this morning. Source: f11photo/Shutterst...

Which Biotech Penny Stocks Are Investors Watching Today? Biotech penny stocks remain some of the most popular securities in 2021. While Covid has helped to highlight the industry at large, each individual company has something different to offer. When looking for a biotech penny stock, ...

BioLineRx Announces Presentation at 2021 American Association for Cancer Research (AACR) Annual Meeting - Poster includes analysis of results by liver metastases, further strengthening results reported in December 2020 of the COMBAT/KEYNOTE-202 triple combination study of motixa...

Severn Bancorp (SVBI +82% on merger agreement with Shore Bancshares.Tanger Factory Outlet Centers (SKT) +21%.Allied Esports Entertainment (AESE) +19%.Bellicum Pharmaceuticals (BLCM +14% on first reported use of CaspaCIDe® Safety Switch.Soligenix (SNGX +14% o...

BioLineRx Ltd. (BLRX) Q4 2020 Earnings Conference Call February 23, 2021 10:00 AM ET Company Participants Timothy McCarthy - LifeSci Advisors Phil Serlin - Chief Executive Officer Mali Zeevi - Chief Financial Officer Avi Vainstein - Chief Medical Officer Ella Sorani - Chief Development Office...

BioLineRx Reports Year-End 2020 Financial Results and Provides Corporate Update - Phase 3 GENESIS study in stem-cell mobilization (SCM) showed statistically significant positive results for primary endpoint in interim analysis; enrollment ceased early; top-line data expected ear...

BioLineRx to Report Annual 2020 Results on February 23, 2021 Management to hold conference call at 10:00 a.m. EST PR Newswire TEL AVIV, Israel , Feb. 17, 2021 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceut...

Cheap Penny Stocks to Watch as the Bull Market Returns Tuesday, February 2nd, was a strong day for both blue chip and penny stocks . While the past few weeks of trading have been quite volatile, the market’s overall sentiment right now seems to be bullish. There are a few pos...

BioLineRx Ltd. is a late-stage biopharmaceutical company focused on oncology with 2 multi-indication candidates (Phase 3 and Phase 1/2a) and 1 approved product. BioLineRx's pipeline and products consist of one "off-strategy" legacy commercialized Class 2a medical device (BL-5010 for s...

BioLineRx Announces Closing of $34.5 Million Bought Deal Offering and Full Exercise of the Option of the Underwriter PR Newswire TEL AVIV, Israel , Jan. 22, 2021 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical c...